From Our Thought Leaders

Enzene Biosciences Appoints Norm Stoffregen as SVP and Head of New $50 Million Biologics Manufacturing Facility in New Jersey

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced the appointment of Norm Stoffregen as SVP, site head, and head of biologics manufacturing at the company’s new $50 ... Read more

04 September, 2024 | Wednesday | News
MasterControl Appoints Kelly Starman as Chief Marketing Officer to Drive Global Growth

MasterControl, a leading provider of quality management and manufacturing software solutions, today announced the appointment of Kelly Starman as Chief Marketing Officer (CMO). Starman brings to MasterControl over two decades of experience spearhea... Read more

15 August, 2024 | Thursday | News
Merck CEO Belén Garijo Drives Up 2024 Growth Forecast as Q2 Results Reflect Robust Performance in Healthcare and Electronics

Financial results of Q2 2024 Group net sales up organically by 1.7% to € 5.4 billion EBITDA pre down 0.8% organically to € 1.5 billion against high comparative base Healthcare and Electronics deliver organic sales grow... Read more

12 August, 2024 | Monday | Company results
Twist Bioscience Surpasses Revenue Guidance with $81.5 Million, Says CEO Emily M. Leproust; Highlights Strength in NGS and SynBio Product Lines

– Record revenue of $81.5M in 3QFY24, an increase of 28% over $63.7M in 3QFY23 – – Gross margin improved to 43.3% in 3QFY24, increasing approximately 900 basis points over 34.4% in 3QFY23 – — Increased FY 2024 re... Read more

05 August, 2024 | Monday | Company results

Bio Finance

EQT Private Capital Asia Acquires Controlling Stake in GeBBS Healthcare Solutions to Drive Global Expansion

GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM), and medical billing services It offers a range of services designed to help US-based healthca... Read more

09 September, 2024 | Monday | News
Nxera Pharma to Receive $35 Million Milestone Payment from Neurocrine Following Successful Phase 2 Schizophrenia Trial

Nxera Pharma Co – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Biosciences (‘Neurocrine’), triggered by the successful completion of the Phase 2 tri... Read more

03 September, 2024 | Tuesday | News

Contract Services

Scantox Group Acquires UK-Based Gentronix to Expand Genetic Toxicology Services

Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for ... Read more

09 September, 2024 | Monday | News
Hongene Biotech and ReciBioPharm Forge Strategic Alliance to Enhance Gene Editing Drug Manufacturing

Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, have announced a strategic collaboration that will enhance gene editing drug manufacturing capabil... Read more

09 September, 2024 | Monday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close